Authors
Latest:
Economic Model of Granulocyte Colony-Stimulating Factors for Patients Receiving ChemotherapyFor US payers, pegfilgrastim is a less-expensive choice than daily filgrastim for reducing the risk of febrile neutropenia in patients receiving myelosuppressive chemotherapy.
Latest:
Does Your Controlled Substance Compliance Program Adequately Address Pharmacists’ Corresponding Responsibility?Pharmacists struggling to reconcile their duty to dispense with legal obligations to prevent drug diversion must exercise judgment when determining whether a prescription is suspect or legitimate.Â
Latest:
Persistence With Mirabegron Versus Tolterodine in Patients With Overactive BladderIn a retrospective analysis of the Optum database, overactive bladder patients treated with mirabegron bladder patients persisted longer with treatment than patients treated with tolterodine, and had reduced resource utilization and costs.
Latest:
Help Patients Manage Cold and Flu SymptomsConsider patients' disease states, medication regimens, and other regularly used nonprescription drugs.
Latest:
Lisocabtagene Maraleucel: A Review of IndicationsLisocabtagene maraleucel chimeric antigen receptor T-cell therapy significantly enhances treatment of relapsed/refractory B-cell malignancies, offering high response rates and durable remissions.
Latest:
Ask Questions, Get Feedback to Make the Most of APPE RotationsTo maximize this challenging experience, pharmacy students should be eager to learn and inquisitive.
Latest:
Improve the Pharmaceutical Ecosystem for PatientsHealth care policy decisions based on sound data and research are essential for addressing the challenges.
Latest:
How to Support Patients and Ensure Adherence to Specialty TherapiesAlthough specialty therapies have the potential to help people live healthier lives, their cost and complexity can create distinct challenges.
Latest:
Five Trends Transforming Pharmacies into Wellness Centers of the FutureWith so many radical developments in medicine and technology unfolding at once, the role and potential of the pharmacy as we know it is evolving at breakneck speed.
Latest:
Pirtobrutinib and BTK Inhibitors in the CLL Treatment LandscapeThis review discusses the prevalence, mechanisms of development, and evolving treatment landscape in chronic lymphocytic leukemia.
Latest:
Review of 3 Alternative Pathways to Access Non–FDA-Approved DrugsNon–FDA-approved medications may be accessed for patient care via 3 alternative pathways: expanded access, the Right to Try Act, and off-label use, which are reviewed in this article.
Latest:
Pharmacist Workload Expected to Increase Again This Fall: How Technology Can HelpThere is a real opportunity for technology to alleviate some of the administrative burdens pharmacists face so that they have more time to focus on patient care.
Latest:
Educational Opportunities Exist for the Pharmaceutical Care of AnimalsInterested individuals may gain certification or continuing-education credits, many of which are available through the American College of Veterinary Pharmacists.
Latest:
Making Prescription Labels Easier to UnderstandPrescription labels have a lot of details on them, which can make it difficult for patients to find and use important information.
Latest:
Accessibility Is Key for the Psychedelic RevolutionUse of these drugs as medications, though, promising, may be restricted for various reasons to a select few.
Latest:
Prescription for Protection: Cybersecurity Measures for Health Care ProfessionalsProactive strategies to protect health care data from hackers.
Latest:
Supporting the Evolving Retail Pharmacy Landscape While Improving Medication AdherenceMobile apps can help consumers acquire medications, but few help with adherence beyond automatic refills or medication synchronization.
Latest:
Trends in Emergency Department Follow-Up ProgramsPharmacy personnel can be integrated to optimize antimicrobial use.
Latest:
Eleven Potentially Practice-Changing Drugs Were Approved by the FDA in 2023These drugs have interesting mechanisms, unique use, or may support expanded indications in the future.
Latest:
Adverse Effects Impact Treatment Selection for VEGF-Targeted Oral TKIs in Metastatic RCCAxitinib, cabozantinib, and lenvatinib are first-line treatment options.
Latest:
Paxlovid’s Double-Edged Sword: Treating COVID-19 and the Risk of Viral Load ReboundThe conversation of VLR has sparked a discussion as to whether or not other COVID-19 treatment agents are associated with a surge in symptoms and if so, how those agents compare with the rebound effect of nirmatrelvir/ritonavir.
Latest:
Our Shot to Stop the Pandemic: A Student's PerspectivePharmacists can advocate for teen vaccination by providing informational sessions at local high schools as well as through social media platforms.
Latest:
Surprising Drugs That Can Cause Serotonin SyndromeSpecific drugs, foods, and supplements can lead to this condition.
Latest:
Practice Pearl 3: Reducing Costs of PARPi for Ovarian Cancer TreatmentExperts in gynecologic oncology provide insight on available patient assistance programs to help lower costs of PARP inhibitors for the treatment of ovarian cancer, and how pharmacists can aid in obtaining this information.
Latest:
Coping With Burnout in the PharmacyMitigating the likelihood of pharmacy staff burnout requires a multifactorial approach.
